Rafael Gisbert‐Criado

1.6k total citations
8 papers, 156 citations indexed

About

Rafael Gisbert‐Criado is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Rafael Gisbert‐Criado has authored 8 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Rafael Gisbert‐Criado's work include Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). Rafael Gisbert‐Criado is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). Rafael Gisbert‐Criado collaborates with scholars based in Spain, Germany and Netherlands. Rafael Gisbert‐Criado's co-authors include José Vidal-Martínez, Óscar Juan, José Muñoz-Langa, José Gómez‐Codina, John A. Foekens, Johann S. de Bono, Stefan Sleijfer, Michiel Strijbos, Tanja Fehm and Dieter Peeters and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cardiology and Cytometry Part B Clinical Cytometry.

In The Last Decade

Rafael Gisbert‐Criado

7 papers receiving 154 citations

Peers

Rafael Gisbert‐Criado

ONCOL

CR

PRM

BE

MB

Antoine Vasseur France

Mireia Melé Spain

Kathleen Harnden United States

Emerik Österlund Sweden

Ángel Rodríguez United States

Dimitris Mavroudis Greece

Maxim Freydin United Kingdom

Mohammed Absar United Kingdom

Felipe Silva Rodrigues United Kingdom

Lonneke W. Kessels Netherlands

Antoine Vasseur France

Rafael Gisbert‐Criado

107 ×0.9

ONCOL

87 ×1.0

CR

43 ×0.7

PRM

22 ×0.8

BE

43 ×2.4

MB

Citations per year, relative to Rafael Gisbert‐Criado Rafael Gisbert‐Criado (= 1×) peers Antoine Vasseur

Countries citing papers authored by Rafael Gisbert‐Criado

Since Specialization

Citations

This map shows the geographic impact of Rafael Gisbert‐Criado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Gisbert‐Criado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Gisbert‐Criado more than expected).

Fields of papers citing papers by Rafael Gisbert‐Criado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Gisbert‐Criado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Gisbert‐Criado. The network helps show where Rafael Gisbert‐Criado may publish in the future.

Co-authorship network of co-authors of Rafael Gisbert‐Criado

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Gisbert‐Criado. A scholar is included among the top collaborators of Rafael Gisbert‐Criado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Gisbert‐Criado. Rafael Gisbert‐Criado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Gisbert‐Criado, Rafael, et al.. (2022). Cardiac telerehabilitation with long-term follow-up reduces GlycA and improves lipoprotein particle profile: A randomised controlled trial. International Journal of Cardiology. 369. 60–64. 6 indexed citations

2.

Garde, J., Eloísa Jantus‐Lewintre, José Vidal-Martínez, et al.. (2019). Soluble biomarker signature to predict outcome of patients with non-small-cell lung cancer (NSCLC) treated with anti-PD1/PDL1 monoclonal antibodies.. Journal of Clinical Oncology. 37(15_suppl). e20685–e20685. 1 indexed citations

3.

Morales, Serafín, Ana Velasco, José Vidal-Martínez, et al.. (2018). Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer. Cancer Treatment and Research Communications. 16. 13–17. 4 indexed citations

4.

Cosı́n-Sales, Juan, et al.. (2017). Mejora del tratamiento de la dislipemia para pacientes con muy alto riesgo cardiovascular en la práctica clínica. Proyecto COLIPAR. Revista Española de Cardiología. 71(11). 979–980. 2 indexed citations

5.

Juan, Óscar, et al.. (2013). Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine. Clinical & Translational Oncology. 16(7). 637–643. 50 indexed citations

6.

Rodero, M., Rafael Gisbert‐Criado, Pilar Herrera Puente, et al.. (2011). The effect of anti-Anisakis simplexantibody levels on C3 and C4 complement components in human sera. Journal of Helminthology. 86(2). 197–201. 2 indexed citations

7.

Kraan, Jaco, Stefan Sleijfer, Michiel Strijbos, et al.. (2010). External quality assurance of circulating tumor cell enumeration using the CellSearch^® system: A feasibility study. Cytometry Part B Clinical Cytometry. 80B(2). 112–118. 85 indexed citations

8.

Esteban, Emilio, et al.. (2008). Circulating tumor cells in breast cancer: methodology and clinical repercussions. Clinical & Translational Oncology. 10(7). 399–406. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact